Nevertheless, since the AS1411 aptamer has been shown to potently bind to PDAC cells in other studies, and since MUC1 is expressed in PDAC cells as well [78], metal (nano) formulations of both the AS1411- and the anti-MUC1- aptamer could potentially be used as radiosensitizers for pancreatic cancer. The gene discussed is MUC1; the disease is pancreatic neoplasm.